Radioactive smart probe for potential corrected matrix metalloproteinase imaging

Bioconjugate Chemistry

Volumn 23, Issue 11, 2012, Pages 2159-2167

  Huang, Chiun Wei ^a   Li, Zibo ^a   Conti, Peter S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE IMAGING; OPTICAL IMAGE STORAGE; PROBES;

DEPTH PENETRATION; ENZYMES ACTIVITY; IN-VIVO; MATRIX; METALLOPROTEINASES; MMP ACTIVITY; NATIVE FORMS; OPTICAL PROBE; PENETRATION PROPERTY; SMART PROBES;

ENZYME ACTIVITY;

MATRIX METALLOPROTEINASE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME SPECIFICITY; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; QUORUM SENSING; RADIOACTIVITY;

EID: 84869740674     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc3001968     Document Type: Article

References (34)

1. Richmond, T. D. (2008) The current status and future potential of personalized diagnostics: Streamlining a customized process Biotechnol. Annu. Rev. 14, 411-422
2. Walk, E. E. (2010) Improving the power of diagnostics in the era of targeted therapy and personalized healthcare Curr. Opin. Drug Discovery Devel. 13, 226-234
3. Massoud, T. F. and Gambhir, S. S. (2007) Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm Trends Mol. Med. 13, 183-191
4. Gross, S. and Piwnica-Worms, D. (2006) Molecular imaging strategies for drug discovery and development Curr. Opin. Chem. Biol. 10, 334-342
5. Hilderbrand, S. A. and Weissleder, R. (2010) Near-infrared fluorescence: application to in vivo molecular imaging Curr. Opin. Chem. Biol. 14, 71-79
6. Mahmood, U. and Weissleder, R. (2003) Near-infrared optical imaging of proteases in cancer Mol. Cancer Ther. 2, 489-496
7. Rao, J., Dragulescu-Andrasi, A., and Yao, H. (2007) Fluorescence imaging in vivo: recent advances Curr. Opin. Biotechnol. 18, 17-25
8. Kosaka, N., Ogawa, M., Choyke, P. L., and Kobayashi, H. (2009) Clinical implications of near-infrared fluorescence imaging in cancer Future Oncol. 5, 1501-1511
9. Ntziachristos, V., Bremer, C., and Weissleder, R. (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging Eur. Radiol. 13, 195-208
10. Sbardella, D., Fasciglione, G. F., Gioia, M., Ciaccio, C., Tundo, G. R., Marini, S., and Coletta, M. Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processes. Molecular Aspects of Medicine. 2011, not supplied.
11. Malemud, C. J. (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview Front. Biosci. 11, 1696-1701
12. Deryugina, E. I. and Quigley, J. P. (2010) Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions Biochim. Biophys. Acta 1803, 103-120
13. Candelario-Jalil, E., Yang, Y., and Rosenberg, G. A. (2009) Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia Neuroscience 158, 983-994
14. Pellikainen, J. M., Ropponen, K. M., Kataja, V. V., Kellokoski, J. K., Eskelinen, M. J., and Kosma, V. M. (2004) Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis Clin. Cancer Res. 10, 7621-7628
15. Deryugina, E. I. and Quigley, J. P. (2006) Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev. 25, 9-34
16. Davis, G. E., Stratman, A. N., Sacharidou, A., and Koh, W. (2011) Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting Int. Rev. Cell Mol. Biol. 288, 101-165
17. Yoon, S. O., Park, S. J., Yun, C. H., and Chung, A. S. (2003) Roles of matrix metalloproteinases in tumor metastasis and angiogenesis J. Biochem. Mol. Biol. 36, 128-137
18. Zhang, B., Cao, X., Liu, Y., Cao, W., Zhang, F., Zhang, S., Li, H., Ning, L., Fu, L., Niu, Y., Niu, R., Sun, B., and Hao, X. (2008) Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer BMC Cancer 8, 83
19. Coussens, L. M., Fingleton, B., and Matrisian, L. M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295, 2387-2392
20. Chetty, C., Rao, J. S., and Lakka, S. S. (2011) Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma Pharmacogenomics 12, 535-546
21. Kamiya, M., Kobayashi, H., Hama, Y., Koyama, Y., Bernardo, M., Nagano, T., Choyke, P. L., and Urano, Y. (2007) An enzymatically activated fluorescence probe for targeted tumor imaging J. Am. Chem. Soc. 129, 3918-3929
22. Ogawa, M., Kosaka, N., Longmire, M. R., Urano, Y., Choyke, P. L., and Kobayashi, H. (2009) Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases Mol. Pharmaceutics 6, 386-395
23. Deguchi, J. O., Aikawa, M., Tung, C. H., Aikawa, E., Kim, D. E., Ntziachristos, V., Weissleder, R., and Libby, P. (2006) Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo Circulation 114, 55-62
24. Johansson, N., Vaalamo, M., Grénman, S., Hietanen, S., Klemi, P., Saarialho-Kere, U., and Kähäri, V. M. (1999) Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas Am. J. Pathol. 154, 469-480
25. Nannuru, K. C., Futakuchi., M., Varney, M. L., Vincent, T. M., Marcusson, E. G., and Singh, R. K. (2010) Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-boneinterface Cancer Res. 70, 3494-3504
26. Hsu, C. P., Shen., G. H., and Ko, J. L. (2006) Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer Lung Cancer 52, 349-357
27. Komatsu, K., Nakanishi, Y., Nemoto, N., Hori, T., Sawada, T., and Kobayashi, M. (2004) Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomas Brain Tumor Pathology 21, 105-112
28. Gessi, S., Sacchetto, V., Fogli, E., Merighi, S., Varani, K., Baraldi, P. G., Tabrizi, M. A., Leung, E., Maclennan, S., and Borea, P. A. (2010) Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors Biochem. Pharmacol. 79, 1483-1495
29. Huang, C. W., Li, Z., Cai, H., Shahinian, T., and Conti, P. S. (2011) Biological stability evaluation of the α2β1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide Bioconjugate Chem. 22, 256-263
30. Huang, C. W., Li, Z., Cai, H., Chen, K., Shahinian, T., and Conti, P. S. (2011) Design, synthesis and validation of integrin α2β1-targeted probe for microPET imaging of prostate cancer Eur. J. Nucl. Med. Mol. Imaging 38, 1313-1322
31. Bremer, C., Bredow, S., Mahmood, U., Weissleder, R., and Tung, C. H. (2001) Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model Radiology 221, 523-529
32. Zhu, L., Xie, J., Swierczewska, M., Zhang, F., Quan, Q., Ma, Y., Fang, X., Kim, K., Lee, S., and Chen, X. (2011) Real-time video imaging of protease expression in vivo Theranostics 1, 18-27
33. Sheth, R. A., Maricevich, M., and Mahmood, U. (2010) In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate Atherosclerosis 212, 181-187
34. Ogawa, M., Regino, C. A., Seidel, J., Green, M. V., Xi, W., Williams, M., Kosaka, N., Choyke, P. L., and Kobayashi, H. (2009) Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection Bioconjugate Chem. 20, 2177-2184